BLUE BELL, Pa., November 18, 2025--(BUSINESS WIRE)--inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study ...
The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...
Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.
LAGUNA HILLS, Calif., May 21, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results